Home/ Supplements/ Niacin/ Life Extension Mix Tablets With Extra Ni...

Life Extension Mix Tablets With Extra Niacin & Without Copper

product on market Tablet or Pill Life Extension Safety: 98/100
98/100

This product looks safe

  • Niacin: 862mg is 24.6× the Tolerable Upper Intake Level (35mg)
  • Vitamin B6: 105mg is 1.1× the Tolerable Upper Intake Level (100mg)
  • Magnesium: 400mg is 1.1× the Tolerable Upper Intake Level (350mg)
  • 58% of ingredients have research evidence
F Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

This formula contains essential vitamins such as A, C, D3, and E, which are supported by strong evidence for maintaining immune function and cellular health. Thiamine serves as a critical cofactor for energy metabolism. While these ingredients have extensive research backing, the overall evidence coverage for this specific blend is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 862mg is 24.6× the Tolerable Upper Intake Level (35mg)

Vitamin B6: 105mg is 1.1× the Tolerable Upper Intake Level (100mg)

Magnesium: 400mg is 1.1× the Tolerable Upper Intake Level (350mg)

Label

Product Label

Label for Life Extension Mix Tablets With Extra Niacin & Without Copper
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Tablet(s)
Serving Size
35
Servings
Other Combinations
Product Type
58%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
5000 IU (100% DV)
Vitamin C
2000 mg (3333% DV)
200 IU (500% DV)
Within RDA (0.3× RDA) 608 studies (A:16, B:251)
100 UI (333% DV)
6.7× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)
125 mg (8333% DV)
104.2× RDA — above typical dose 76 studies (A:0, B:33)
50 mg (2941% DV)
38.5× RDA — above typical dose 13 studies (A:0, B:1)
862 mg (4310% DV)
Exceeds UL by 24.6× (UL: 35 mg) 196 studies (A:5, B:63)
105 mg (5250% DV)
Exceeds UL by 1.1× (UL: 100 mg) 114 studies (A:3, B:35)
400 mcg (100% DV)
Within RDA (1.0× RDA) 226 studies (A:10, B:105)
600 mcg (10000% DV)
250.0× RDA — above typical dose 139 studies (A:1, B:44)
3000 mcg (1000% DV)
100.0× RDA — above typical dose 27 studies (A:0, B:11)
600 mg (6000% DV)
120.0× RDA — above typical dose 2 studies — no high-quality reviews
Calcium
218 mg (22% DV)
150 mcg (100% DV)
Within RDA (1.0× RDA) 245 studies (A:4, B:133)
400 mg (100% DV)
Exceeds UL by 1.1× (UL: 350 mg) 316 studies (A:8, B:159)
35 mg (233% DV)
3.2× RDA — above typical dose (UL: 40 mg) 263 studies (A:6, B:134)
200 mcg (286% DV)
3.6× RDA — above typical dose (UL: 0.4 mg) 173 studies (A:0, B:67)
1 mg (50% DV)
Within RDA (0.4× RDA) 9 studies — no high-quality reviews
500 mcg (417% DV)
14.3× RDA — above typical dose 199 studies (A:1, B:55)
125 mcg (167% DV)
2.8× RDA — within safe limits 3 studies — no high-quality reviews
Potassium
37.4 mg (1% DV)
N-Acetyl-L-Cysteine
600 mg
200 mg
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)
Within RDA (0.3× RDA) 38 studies (A:1, B:7)
120 mg
Within RDA (0.2× RDA) 38 studies (A:1, B:7)
3 mg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews
Market median: 496.0mg (192 products) 20 studies — no high-quality reviews
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
Broccoli Concentrate Blend
725 mg
Market median: 260.0mg (249 products) 158 studies (A:4, B:61)
Acerola extract
300 mg
Fruit/Berry Complex
200 mg
Wild Blueberry Anthocyanin extract
150 mg
Market median: 250.0mg (562 products) 55 studies (A:0, B:19)
Maqui berry (Aristotelia chilensis) Anthocyanin extract
100 mg
Market median: 100.0mg (284 products) 10 studies (A:0, B:4)
Market median: 250.0mg (182 products) 10 studies (A:0, B:2)
4.0× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)
Market median: 100.0mg (120 products)
Market median: 100.0mg (284 products) 10 studies (A:0, B:4)
Market median: 100.0mg (284 products) 10 studies (A:0, B:4)
15 mg
Market median: 200.0mg (136 products) 3 studies — no high-quality reviews
Delphinidins
2 mg
15 mg
Market median: 10.0mg (105 products) 2 studies (A:0, B:1)
Olive juice extract
12.5 mg
Market median: 200.0mg (52 products) 12 studies (A:0, B:6)
Luteolin
8 mg
3 mg
Market median: 10.0mg (35 products) 6 studies (A:0, B:2)
Cyanidin-3-Glucoside
1.25 mg
Market median: 167.0mg (311 products) 183 studies (A:0, B:65)

Other Ingredients

Dicalcium Phosphate Microcrystalline Cellulose Hydroxypropyl Cellulose Croscarmellose Sodium Stearic Acid Vegetable Stearate Silica Pharmaceutical Glaze Maltodextrin
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take nine (9) tablets per day in divided doses with meals, or as recommended by a healthcare practitioner.

Warnings & Precautions

Caution: Temporary flushing, itching, rash, or gastric disturbances may occur. Liver function testing is recommended when niacin is taken in excess of 500 mg daily. Those with gout or liver diseases should avoid taking high doses of niacin.

Consult with your doctor before using this product if you are taking anticoagulant medications.

Individuals consuming more than 2,000 IU/day of vitamin D (from diet and supplements) should periodically obtain a serum 25-hydroxy vitamin D measurement. Vitamin D supplementation is not recommended for individuals with high blood calcium levels.

Contains fish (tilapia) and soybeans.

Warnings: - Keep out of reach of children.

- Do not exceed recommended dose. - Do not purchase if outer seal is broken or damaged.

- When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.

Formulation Notes

Life extension mix tablets with extra Niacin & without Copper

Contains fish (tilapia) and soybeans.

Life extension mix tablets with extra Niacin & without Copper

Additional Information

State-of-the-art multi-nutrient formula

QE01867B

To report a serious adverse event or obtain product information, contact 1-866-280-2852.

Warning: This product contains a chemical known to the State of California to cause birth defects or other reproductive harm. Store tightly closed in a cool, dry place.

Scan for product info

Metadata

Product Details

UPC / SKU7 37870 18673 1
DSLD Entry Date2016-06-24
Product TypeOther Combinations
FormTablet or Pill
BrandLife Extension
DSLD ID60911
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

Rezistaf
LifeLink · Tablet or Pill
100
Coenzymated B-3 25 mg
Source Naturals · Tablet or Pill
100
Vitamin B Complex
Simply Supplements · Tablet or Pill
100
Test X180 Boost
Force Factor · Tablet or Pill
100
8-Hour Alert
MHP Maximum Human Performance · Tablet or Pill
100
View all Niacin products →
Niacin research Best Niacin All Niacin products More from Life Extension View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.